Biotech Investors & VC Firms in United Kingdom

294 firms in this list, with a median first check of $500K. 62 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
OR ORI Capital SSDTGSYE15 people	88🔒	Hong Kong	HK	Pre-Seed–Late Stage	—	+ Add to CRM
SO Sound Bioventures CBJKAGES9 people · Leads rounds	88🔒	Malmö	SE	Seed–Late Stage	—	+ Add to CRM
AD AdBio partners AHCBGD3 people	88🔒	Paris	FR	Pre-Seed–Series A	—	+ Add to CRM
PA Panakes Partners FLLBMSAP13 people · Follows rounds	88🔒	Milan	IT	Seed–Late Stage	—	+ Add to CRM
RT RTW Investments L.P. GMJMJKLC14 people	88🔒	New York	US	Seed–Series A	—	+ Add to CRM
DI Diffusion Capital Partners AKFOFÖAK10 people · Follows rounds	88🔒	Istanbul	TR	Pre-Seed–Series A	$439K – $2.7M	+ Add to CRM
PM PM Equity Partner DSSIWMAG10 people	88🔒	Lausanne	CH	Series A–Growth	$2M – $50M	+ Add to CRM
SE Sectoral Asset Management FBGDCKOR9 people	88🔒	Montreal	CA	Series A–Late Stage	—	+ Add to CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLSV12 people	88🔒	Contern	LU	Seed–Late Stage	$10.8M	+ Add to CRM
SI Sista TJMGNBAH6 people · Leads rounds	88🔒	Paris	FR	Seed–Series A	—	+ Add to CRM
TV TVM Capital DHHBSFDH6 people · Leads rounds	88🔒	Munich	DE	Seed–Late Stage	$1.1M – $16.2M	+ Add to CRM
JJ JJDC TMAKMNFM11 people	88🔒	New Brunswick	US	Seed–Series B	$500K – $5M	+ Add to CRM
PR Propagator Ventures AFAEETAA7 people	88🔒	Oslo	NO	Pre-Seed–Series A	—	+ Add to CRM
IA IAG Capital Partners JWAKSC3 people · Leads rounds	88🔒	Charleston	US	Seed–Late Stage	—	+ Add to CRM
EG EGORA Ventures AG BLNZDNPA7 people	88🔒	Martinsried	DE	Pre-Seed–Series B	$5.4M	+ Add to CRM
VI VIVES Partners PDSSYVAV4 people	88🔒	Wavre	BE	Pre-Seed–Series B	$108K – $7.6M	+ Add to CRM
LE Legendary Ventures, Llc. JDMLAKZD9 people	88🔒	New York City	US	Seed–Late Stage	—	+ Add to CRM
FU Future Positive Capital PR1 person · Follows rounds	88🔒	—	FR	Pre-Seed–Series A	—	+ Add to CRM
ED EDB Investments CKCLCGJO11 people	88🔒	Singapore	SG	Seed–Late Stage	$12M – $400M	+ Add to CRM
VE Vento DDJKTMIT4 people · Follows rounds	88🔒	Torino	IT	Pre-Seed–Seed	$165K – $1.1M	+ Add to CRM
GR GRIDS Capital IPPCGP3 people	88🔒	São Paulo	BR	Seed–Late Stage	—	+ Add to CRM
DE DEFTA Partners KWGHMIST5 people	88🔒	San Francisco	US	Seed–Series A	—	+ Add to CRM
EM EMBL Ventures CL1 person	88🔒	Heidelberg	DE	Seed–Late Stage	$108K – $5.4M	+ Add to CRM
IN Innovation Nest WDDDDGKF10 people	88🔒	Krakow	PL	Seed–Series A	$108K – $1.1M	+ Add to CRM

ORI Capital

Hong KongPre-Seed–Late Stage

SSDTGSYE15 people

Sound Bioventures

MalmöSeed–Late Stage

CBJKAGES9 people

AdBio partners

ParisPre-Seed–Series A

AHCBGD3 people

Panakes Partners

MilanSeed–Late Stage

FLLBMSAP13 people

RTW Investments L.P.

New YorkSeed–Series A

GMJMJKLC14 people

Diffusion Capital Partners

IstanbulPre-Seed–Series A$439K – $2.7M

AKFOFÖAK10 people

PM Equity Partner

LausanneSeries A–Growth$2M – $50M

DSSIWMAG10 people

Sectoral Asset Management

MontrealSeries A–Late Stage

FBGDCKOR9 people

Vesalius Biocapital III Partners SàRL

ConternSeed–Late Stage$10.8M

CSGGMLSV12 people

Sista

ParisSeed–Series A

TJMGNBAH6 people

TVM Capital

MunichSeed–Late Stage$1.1M – $16.2M

DHHBSFDH6 people

JJDC

New BrunswickSeed–Series B$500K – $5M

TMAKMNFM11 people

Propagator Ventures

OsloPre-Seed–Series A

AFAEETAA7 people

IAG Capital Partners

CharlestonSeed–Late Stage

JWAKSC3 people

EGORA Ventures AG

MartinsriedPre-Seed–Series B$5.4M

BLNZDNPA7 people

VIVES Partners

WavrePre-Seed–Series B$108K – $7.6M

PDSSYVAV4 people

Legendary Ventures, Llc.

New York CitySeed–Late Stage

JDMLAKZD9 people

Future Positive Capital

Pre-Seed–Series A

PR1 person

EDB Investments

SingaporeSeed–Late Stage$12M – $400M

CKCLCGJO11 people

Vento

TorinoPre-Seed–Seed$165K – $1.1M

DDJKTMIT4 people

GRIDS Capital

São PauloSeed–Late Stage

IPPCGP3 people

DEFTA Partners

San FranciscoSeed–Series A

KWGHMIST5 people

EMBL Ventures

HeidelbergSeed–Late Stage$108K – $5.4M

CL1 person

Innovation Nest

KrakowSeed–Series A$108K – $1.1M

WDDDDGKF10 people

Data sourced from public filings and firms' own websites — see our methodology.